Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Palmitoylethanolamide
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase II
Recipient : University of California, Irvine
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 08, 2022
Lead Product(s) : Palmitoylethanolamide
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II
Recipient : University of California, Irvine
Deal Size : Inapplicable
Deal Type : Inapplicable